S.CHANDRA SEKHAR's Insider Trades & SAST Disclosures
S.CHANDRA SEKHAR's most recent trade in Vanta Bioscience Ltd. was a Acquisition of 400,000 Equity Shares done at an average price of Rs. 50 . Disclosure was reported to the exchange on May 9, 2025 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for S.CHANDRA SEKHAR in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vanta Bioscience | S Chandra Sekhar Rao | Promoter | Acquisition | 09 May 2025 | 400,000 | 522,500 (7.35%) | 5.62% | 50 | 20,000,000 | 06 May 2025 06 May 2025 |
Insider Trading | Equity Shares | Preferential Offer |
| Bhagiradha Chemicals | S.CHANDRA SEKHAR | Promoter & Director | Pledge | 10 Aug 2020 | 666,000 | 1,287,300 (15.49%) | 7.99% | 0.0 | 8 | 06 Aug 2020 06 Aug 2020 |
Insider Trading | Equity Shares | Creation Of Pledge |
| Bhagiradha Chemicals | S.CHANDRA SEKHAR | Promoter & Director | Revoke | 30 Jul 2020 | 666,000 | 1,287,300 (15.49%) | 7.99% | 285.1 | 189,843,300 | 22 Jul 2020 22 Jul 2020 |
Insider Trading | Equity Shares | Pledge Released |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.